Evidence map›Paper›PMID 22116276›Full record

ArticleJournal of biosciences2011

The membranotropic activity of N-terminal peptides from the pore-forming proteins sticholysin I and II is modulated by hydrophobic and electrostatic interactions as well as lipid composition.

Uris Ros, Lohans Pedrera, DaylÍn Diaz, Juan C De Karam, Tatiane P Sudbrack, Pedro A Valiente, Diana MartÍnez, Eduardo M Cilli, Fabiola Pazos, Rosangela Itri and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biosciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Uris RosCenter for Protein Studies, Biology Faculty, University of Havana, Havana, Cuba.
Lohans Pedrera
DaylÍn Diaz
Juan C De Karam
Tatiane P Sudbrack
Pedro A Valiente
Diana MartÍnez
Eduardo M Cilli
Fabiola Pazos
Rosangela Itri
Maria E Lanio
Shirley Schreier
Carlos Ávarez

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sea anemone Stichodactyla helianthus produces two pore-forming proteins, sticholysins I and II (St I and St II). Despite their high identity (93%), these toxins exhibit differences in hemolytic activity that can be related to those found in their N-terminal. To clarify the contribution of the N-terminal amino acid residues to the activity of the toxins, we synthesized peptides spanning residues 1-31 of St I (StI1-31) or 1-30 of St II (StII1-30) and demonstrated that StII1-30 promotes erythrocyte lysis to a higher extent than StI1-31. For a better understanding of the molecular mechanism underlying the peptide activity, here we studied their binding to lipid monolayers and pemeabilizing activity in liposomes. For this, we examined the effect on peptide membranotropic activity of including phospatidic acid and cholesterol in a lipid mixture of phosphatidylcholine and sphingomyelin. The results suggest the importance of continuity of the 1-10 hydrophobic sequence in StII1-30 for displaying higher binding and activity, in spite of both peptides' abilities to form pores in giant unilamellar vesicles. Thus, the different peptide membranotropic action is explained in terms of the differences in hydrophobic and electrostatic peptide properties as well as the enhancing role of membrane inhomogeneities.

Indexed as

Amino Acid SequenceCnidarian VenomsHydrophobic and Hydrophilic InteractionsLipid BilayersMembrane LipidsMolecular Sequence DataOrganic ChemicalsPeptide FragmentsPermeabilityProtein BindingUnilamellar LiposomesCnidarian VenomsLipid BilayersMembrane LipidsOrganic ChemicalsPeptide Fragmentssticholysin IIstycholysin IUnilamellar Liposomes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.